Navigation Links
Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Company's Anthrax Therapeutic
Date:9/25/2007

with or without an antibiotic."

Anthim(TM) Background

Anthim is high affinity monoclonal antibody that targets the protective antigen component of anthrax infection, blocking the bacteria's ability to form deadly toxins. It is being developed for prophylaxis and post-exposure treatment of inhalation anthrax. Anthim has been granted Fast Track status and Orphan Drug Designation by the FDA and is being developed under the FDA Animal Rule, a regulatory process specifically designed for the development of medical countermeasures to bioterror threats. In April of 2007, Anthim was selected to R&D Directions' list of "100 Great Investigational Drugs.

About Elusys' Heteropolymer Antibody(TM) Technology

HP Antibodies represent a new approach for the treatment of antibiotic resistant infections distinct from traditional therapies. HP Antibodies utilize natural immune system mechanisms to clear pathogens and provide a means to develop novel drug candidates targeted against bacterial, viral and fungal infections. By targeting a unique immune receptor, HP Antibodies enhance a natural clearance mechanism and direct the rapid removal of pathogens from the circulation to tissue macrophages. Elusys is currently working on novel approaches to the treatment of Staphylococcus and Candida infections using HP antibodies.

About Elusys

Elusys is a privately held biopharmaceutical company focused on the development of antibody-based therapeutics for the treatment of life- threatening infectious disease. Current venture investors include Essex Woodlands Health Ventures LLC, Invesco Private Capital, Crescendo Ventures, MedImmune Ventures and Pfizer. For more information please visit http://www.elusys.com.


'/>"/>
SOURCE Elusys Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pelosi: Bush Veto of Stem Cell Bill Says No to the Hopes of Million of Families Across America
2. Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million Annually
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
5. Phase III Clinical Trial with 4-Month Long-Acting Formulation of Triptorelin: Ipsen Decides Not to Perform Further Administration
6. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
7. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
8. Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical Trial Data
9. MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines
10. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
11. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015  Mail-service and ... consumers, employers and government health plans $11.8 ... released by the Pharmaceutical Care Management Association (PCMA). ... drugs offers one of the easiest ways to ... Mark Merritt . "Policymakers should resist efforts ...
(Date:3/4/2015)... KANSAS CITY, Kan. , March 4, 2015 /PRNewswire/ ... ), a pet therapeutics company focused on the licensing, ... animals, today announced that it will present at the ... March 10-12, 2015, at the Loews Miami Beach Hotel ... Steven St. Peter , M.D., President and ...
(Date:3/4/2015)... SAN DIEGO , March 4, 2015 Aethlon ... devices to address infectious diseases and cancer, today announced ... is scheduled to present a corporate overview at the ... The Ritz-Carlton Hotel in Laguna Niguel, California ... click here ( http://www.roth.com/main/page.aspx?PageID=7207 ). A live ...
Breaking Medicine Technology:PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Illinois Employers, Consumers and Public Programs by $11.8 Billion 2Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2Aethlon Medical to Present at the 27th Annual ROTH Conference 2
... 2011 VIVUS, Inc. (NASDAQ: VVUS ) today ... the European Congress on Obesity (ECO) in Istanbul, Turkey.  ECO ... the Study of Obesity (EASO). ECO is regularly attended by ... considered to be the most important annual scientific event on ...
... and Anne Wojcicki announced a $50-million challenge spurring existing and ... to The Michael J. Fox Foundation for Parkinson,s Research (MJFF). ... new or increased gifts to The Michael J. Fox Foundation ... The Brin Wojcicki Challenge will bolster MJFF,s ongoing efforts to ...
Cached Medicine Technology:Additional Data From QNEXA Clinical Trials Presented at the European Congress on Obesity 2Additional Data From QNEXA Clinical Trials Presented at the European Congress on Obesity 3Additional Data From QNEXA Clinical Trials Presented at the European Congress on Obesity 4Additional Data From QNEXA Clinical Trials Presented at the European Congress on Obesity 5Brin Wojcicki Foundation Announces $50-Million Challenge Grant to Michael J. Fox Foundation to Spur Progress Toward Parkinson's Cure 2
(Date:3/4/2015)... (PRWEB) March 04, 2015 More than ... cardiovascular risks potentially associated with low testosterone treatments ( ... announced that it will now require manufacturers to warn ... risk for heart attacks and strokes. In a ... agency also stated that it was requiring testosterone manufacturers ...
(Date:3/4/2015)... March 04, 2015 Alliance Healthcare Foundation ... wellness for those in need in San Diego and ... organizations through its Mission Support Grants program with awards ... organizations applied for AHF’s Mission Support Grants program. Grant ... board of trustees and program committee, as well as ...
(Date:3/4/2015)... March 04, 2015 State officials have ... the School of Public Health at Georgia State University, ... were awarded by Georgia’s Division of Family and Children ... the DFCS Call Center. , The 1-800-CHILDREN Helpline ... providing information and referral services that promote the wellbeing ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 The New ... and lyrical music, will be performed by the award-winning ... Estates, CA, this March 6-22, 2015, on Fridays, Saturdays ... at Peninsula High School (27118 Silver Spur Road, ... hour before the program or may be purchased on-line ...
(Date:3/4/2015)... 2015 The report covers spices ... marketing channels, industry development trend and proposals. The ... including spices definitions, applications and industry chain structure. ... are provided with a focus on history, developments, ... comparison between the international and Chinese situation is ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 4Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 2Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 3Health News:State Funds Child Abuse Helpline Housed At Georgia State 2Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 3
... Speaker Nancy Pelosi issued the following statement today ... Prevention and Tobacco Control Act, which gives the Food ... and marketing. , , "Today, President Obama ... making America healthier. This bipartisan legislation grants the FDA ...
... Park Targets Pittsburgh Children ... United Concordia Dental and the Pittsburgh Pirates organization began several years ago, ... community as Pennsylvanians and the nation struggle with the uncertainty of a ... will team up from 4 to 7 p.m. Monday June 29 at ...
... disorder marked in part by auditory hallucinations and paranoia, can ... when people are ready to stand on their own two ... scientists at UCLA think they are beginning to understand one ... its kind, the researchers used a novel form of brain ...
... MARINO, Calif., June 22 Epeius Biotechnologies ( ... with a dramatic demonstration of single-agent efficacy with its ... (accessible online as of June 16, 2009 in Molecular ... Gene Therapy, www.nature.com/mt/ ) documents the ...
... Washington, D.C.-based law firm of Schmidt & Clark, LLP ... the U.S. Food and Drug Administration where ... Inc. (NYSE: ABT ) failed to disclose multiple reports ... , , In an Associated Press story reported June 20, ...
... , HARBIN, China, June 22 ... Medical" or "the Company") (Nasdaq: CSKI ), ... People,s Republic of China ("PRC"), today announced that it,obtained ... proprietary Sumei,Slim Patch from Heilongjiang Provincial FDA, which will ...
Cached Medicine News:Health News:Davis Vision, United Concordia Dental and The Pittsburgh Pirates Team Up to Provide Free Dental and Vision Screenings 2Health News:Davis Vision, United Concordia Dental and The Pittsburgh Pirates Team Up to Provide Free Dental and Vision Screenings 3Health News:Alterations in brain's white matter key to schizophrenia, UCLA study shows 2Health News:Clinical Studies Validate Cancer Gene Delivery Platform: Landmark Publication Confirms Rexin-G Effectively Targets Metastatic Cancers and Improves Patient Survival 2Health News:Schmidt & Clark, LLP: FDA Reports Show Abbott Labs Subsidiary Failed to Disclose Parasite Eye Infections Tied to Contact Lens Solution 2Health News:China Sky One Medical, Inc. Obtains Production License Renewal for Sumei Slim Patch 2Health News:China Sky One Medical, Inc. Obtains Production License Renewal for Sumei Slim Patch 3
The MINI-TAG™ instrument systems are indicated for ulnar collateral ligament repair, scapholunate dissolution, flexor avulsions, and carpometa-carpal arthroplasty....
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Medicine Products: